BIO urges Sebelius to reconsider proposed limits on gene patents

02/4/2010 | Bloomberg

BIO has called on HHS Secretary Kathleen Sebelius to reject an advisory committee's proposals that would impose limits on the patenting of human genes and commercialization of genetic tests by companies and scientists. In a letter to Sebelius, the chief executive of the trade group and CEOs of prominent biotech firms said, "It is not the time to undertake or recommend policy changes that would undermine the foundations of American life science innovation."

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC